Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period
Aim. To identify factors responsible for the early development of microvascular complications in patients with type 1 diabetes mellitus (DM1)and to evaluate dependence of their prevalence on the type of insulin. Materials and methods. The study carried out from May 2002 to November 2007 included a...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c4494d28b2e46889fe6ad97da38d647 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3c4494d28b2e46889fe6ad97da38d647 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3c4494d28b2e46889fe6ad97da38d6472021-11-14T09:00:14ZEfficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period2072-03512072-037810.14341/2072-0351-5452https://doaj.org/article/3c4494d28b2e46889fe6ad97da38d6472009-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5452https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. To identify factors responsible for the early development of microvascular complications in patients with type 1 diabetes mellitus (DM1)and to evaluate dependence of their prevalence on the type of insulin. Materials and methods. The study carried out from May 2002 to November 2007 included a random sample of patients with DM1 over 10 years in duration(n=5895, 100%, >=20 years) from the Central, Volga, Ural, Siberian, North-West and Southern federal districts. All patients underwentexamination of eye fundus and feet, measurement of microalbuminuria, creatinine, urea, serum lipid spectrum and HbА1с. Results. Mean HbА1с level in patients of group 1 (using insulin analogs) was significantly lower than in group 2 (using homan insulin) (Me 8,5?0,2%;9,7?0,4% SD* respectively) p>0,01. Mean daily insulin dose in group 1 and 2 was >1,0 andLyubov' Leonidovna BolotskayaYury Ivanovich SuntsovIgor Vladislavovich KazakovMarina Vladimirovna ShestakovaIvan Ivanovich DedovEndocrinology Research Centrearticlestate diabetes registryglycated hemoglobinone-step epidemiological surveyinsulin analogsdiabetic nephropathydiabetic retinopathydiabetic foot syndromedelayed physical developmentNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 12, Iss 3, Pp 49-52 (2009) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN RU |
topic |
state diabetes registry glycated hemoglobin one-step epidemiological survey insulin analogs diabetic nephropathy diabetic retinopathy diabetic foot syndrome delayed physical development Nutritional diseases. Deficiency diseases RC620-627 |
spellingShingle |
state diabetes registry glycated hemoglobin one-step epidemiological survey insulin analogs diabetic nephropathy diabetic retinopathy diabetic foot syndrome delayed physical development Nutritional diseases. Deficiency diseases RC620-627 Lyubov' Leonidovna Bolotskaya Yury Ivanovich Suntsov Igor Vladislavovich Kazakov Marina Vladimirovna Shestakova Ivan Ivanovich Dedov Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period |
description |
Aim. To identify factors responsible for the early development of microvascular complications in patients with type 1 diabetes mellitus (DM1)and to evaluate dependence of their prevalence on the type of insulin. Materials and methods. The study carried out from May 2002 to November 2007 included a random sample of patients with DM1 over 10 years in duration(n=5895, 100%, >=20 years) from the Central, Volga, Ural, Siberian, North-West and Southern federal districts. All patients underwentexamination of eye fundus and feet, measurement of microalbuminuria, creatinine, urea, serum lipid spectrum and HbА1с. Results. Mean HbА1с level in patients of group 1 (using insulin analogs) was significantly lower than in group 2 (using homan insulin) (Me 8,5?0,2%;9,7?0,4% SD* respectively) p>0,01. Mean daily insulin dose in group 1 and 2 was >1,0 and |
format |
article |
author |
Lyubov' Leonidovna Bolotskaya Yury Ivanovich Suntsov Igor Vladislavovich Kazakov Marina Vladimirovna Shestakova Ivan Ivanovich Dedov |
author_facet |
Lyubov' Leonidovna Bolotskaya Yury Ivanovich Suntsov Igor Vladislavovich Kazakov Marina Vladimirovna Shestakova Ivan Ivanovich Dedov |
author_sort |
Lyubov' Leonidovna Bolotskaya |
title |
Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period |
title_short |
Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period |
title_full |
Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period |
title_fullStr |
Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period |
title_full_unstemmed |
Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period |
title_sort |
efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period |
publisher |
Endocrinology Research Centre |
publishDate |
2009 |
url |
https://doaj.org/article/3c4494d28b2e46889fe6ad97da38d647 |
work_keys_str_mv |
AT lyubovleonidovnabolotskaya efficiencyofinsulinanalogsinyoungpatientswithtype1diabetesmellitusdebutduringpubertalperiod AT yuryivanovichsuntsov efficiencyofinsulinanalogsinyoungpatientswithtype1diabetesmellitusdebutduringpubertalperiod AT igorvladislavovichkazakov efficiencyofinsulinanalogsinyoungpatientswithtype1diabetesmellitusdebutduringpubertalperiod AT marinavladimirovnashestakova efficiencyofinsulinanalogsinyoungpatientswithtype1diabetesmellitusdebutduringpubertalperiod AT ivanivanovichdedov efficiencyofinsulinanalogsinyoungpatientswithtype1diabetesmellitusdebutduringpubertalperiod |
_version_ |
1718429642350657536 |